UB-MBX-46 is a potent and selective antagonist of the human P2X7 receptor developed by structure-based drug design
Adam C. Oken, Andreea L. Turcu, Eva Tzortzini, Kyriakos Georgiou, Jessica Nagel, Marta Barniol‐Xicota, Garam Kim, So‐Deok Lee, Annette Nicke, Yong‐Chul Kim, Christa Elisabeth Müller, Antonios Kolocouris, Santiago Vázquez, Steven Mansoor
The paper identifies molecular features of the human P2X7 receptor using cryo-EM structures and designs a potent, selective antagonist, UB-MBX-46, with picomolar potency and high selectivity.
bioRxiv · Feb 12, 2025 · PreprintBiochemistry